After a dramatic round-trip from $150.99 to $48.82 and back toward $98, ELF has become one of the most closely watched consumer stocks in the market. The $120 level sits at a natural intersection: it is well above the current price yet still within the range of Wall Street analyst targets, and it represents a round psychological marker that frequently attracts attention from traders and institutional investors alike. For a stock that has delivered 30 consecutive quarters of net sales growth, the question is not whether the business is growing — it is whether that growth can re-accelerate enough to justify a move back toward the upper end of its valuation range.
e.l.f. Beauty, headquartered in Oakland, California, has transformed from a single-brand budget cosmetics company into a multi-brand beauty platform. Its portfolio now includes e.l.f. Cosmetics, e.l.f. Skin, Naturium, Well People, and the recently acquired Rhode skincare brand. The company reported fiscal first-quarter 2027 net sales of approximately $479 million, representing 36% year-over-year growth, and raised its full-year revenue guidance to $1.94–$1.97 billion. Shares have rallied roughly 40% since the May 2026 lows, yet the stock remains well below its 52-week high of $150.99, reflecting persistent investor caution around the core brand's trajectory and broader tariff-related uncertainty affecting Chinese-manufactured goods.
The Rhode acquisition, completed in August 2025 for approximately $1 billion, has emerged as the company's most powerful growth engine. Rhode delivered roughly $390 million in net sales during fiscal 2026 and has been described by management as the most successful brand launch in Sephora's history across North America. International expansion continues, with Rhode now rolling out across Sephora locations in 19 European countries. The brand's unaided consumer awareness remains in the single digits, suggesting a long runway for growth as marketing investment builds recognition.
The newly launched e.l.f. Hair category represents another potential catalyst. Early sell-through data has been strong, with the Gloss Mode Treatment Oil selling out at Target within weeks of launch and social media sentiment running five to seven times above the average new brand introduction. Analysts at Canaccord Genuity estimate the hair care line could reach at least $200 million in annual sales. Bernstein upgraded ELF to Outperform with a $113 price target, explicitly citing hair care as a growth driver comparable to the company's earlier successful expansion into skincare.
Additionally, approximately $50 million in tariff refunds — following a Supreme Court ruling that invalidated certain import duties — provides a one-time financial cushion that management plans to reinvest into marketing and international expansion. These funds could amplify growth in the near term without requiring additional balance sheet leverage. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The core e.l.f. Cosmetics brand remains the largest concern. Organic core brand sales declined in the high single digits during the most recent quarter when excluding the Rhode contribution. A $1 portfolio-wide price increase implemented in August 2025 to offset tariff costs dampened unit volumes more than anticipated, and spring 2026 product innovation underperformed historical benchmarks. Management is now selectively reducing prices on certain items — the Halo Glow skin tint cut from $18 to $14 generated a 38–60% unit lift in testing — but a broader recovery in the core brand is not yet confirmed.
Tariff exposure is another material risk. Approximately 75% of e.l.f.'s production originates in China, making the company sensitive to shifts in trade policy. While tariff rates have moderated from roughly 55% to approximately 35%, sustained or escalating trade tension could pressure margins and force additional pricing decisions that conflict with the brand's value positioning. The company's balance sheet also carries elevated debt following the Rhode acquisition, with a net debt-to-EBITDA ratio near 2x, limiting financial flexibility if growth disappoints.
Wall Street consensus on ELF remains predominantly bullish, with roughly 71% of covering analysts rating the stock a Buy and no firms carrying a Sell rating. However, price targets vary widely, reflecting genuine uncertainty about the pace of recovery. B. Riley Securities holds the Street-high target at $150, while more cautious firms such as Piper Sandler maintain targets closer to $50–$65. The average analyst target sits near $85–$90, though several firms — including Bernstein ($113), Jefferies ($115–$121), and Truist ($130) — have targets that bracket or exceed the $120 level. The dispersion in estimates underscores a core tension: the bull case depends on portfolio diversification succeeding, while the bear case argues that the core brand slowdown may prove structural rather than temporary.
From a technical perspective, ELF is approaching a meaningful test of the $100 psychological resistance level, which also roughly coincides with the stock's 200-day moving average near $76–$80 in recent weeks — though the moving average has been rising as the stock recovers. A sustained break above $100 would place the next major resistance zone between $110 and $120, an area that aligns with multiple analyst price targets and the stock's pre-downtrend consolidation zone from late 2025. On the downside, support has built near $85–$90, where buyers stepped in repeatedly during July and early August 2026. The $48.82 level, representing the May 2026 trough, serves as the longer-term downside anchor.
In my research process, I turn to Tickeron’s AI Daily Buy/Sell Signals to monitor fast-moving names like this one. The tool applies artificial intelligence across thousands of stocks and ETFs to generate real-time Buy, Sell, or Hold signals based on technical patterns, trends, and broader market dynamics. It helps surface potential shifts early, which is useful when evaluating whether a recovery can hold and extend toward higher targets such as $120.
The $120 price target for e.l.f. Beauty is ambitious but grounded in observable business momentum. Rhode's blistering growth, the promising hair care launch, international retail expansion, and improving tariff conditions all provide legitimate pathways for the stock to continue its recovery. However, reaching $120 will almost certainly require the core e.l.f. Cosmetics brand to return to positive organic growth, as no amount of acquisition-driven expansion can fully compensate for sustained weakness in the brand that still generates the majority of company revenue. Investors should monitor consumption data from Nielsen, the pace of international Rhode rollout, early hair care sales trends, and any shifts in trade policy — these variables will collectively determine whether ELF can break through the $100 ceiling and sustain a move toward $120 and beyond.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
ELF saw its Momentum Indicator move below the 0 level on September 08, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned negative. In 71 of the 88 cases, the stock moved further down in the following days. The odds of a decline are at 81%.
The 10-day RSI Indicator for ELF moved out of overbought territory on September 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 50 similar instances where the indicator moved out of overbought territory. In 34 of the 50 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.
The Moving Average Convergence Divergence Histogram (MACD) for ELF turned negative on September 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 35 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 50-day moving average for ELF moved above the 200-day moving average on August 17, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +2.15% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELF advanced for three days, in 263 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
ELF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 242 of 286 cases where ELF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
The Tickeron PE Growth Rating for this company is 29 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. ELF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 74 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.869) is normal, around the industry mean (17.489). ELF has a moderately high P/E Ratio (98.408) as compared to the industry average of (43.367). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (1.704). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (3.174) is also within normal values, averaging (1.884).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company
Industry HouseholdPersonalCare